[HTML][HTML] Fyn phosphorylates AMPK to inhibit AMPK activity and AMP-dependent activation of autophagy

E Yamada, S Okada, CC Bastie, M Vatish, Y Nakajima… - Oncotarget, 2016 - ncbi.nlm.nih.gov
E Yamada, S Okada, CC Bastie, M Vatish, Y Nakajima, R Shibusawa, A Ozawa, JE Pessin…
Oncotarget, 2016ncbi.nlm.nih.gov
We previously demonstrated that proto-oncogene Fyn decreased energy expenditure and
increased metabolic phenotypes. Also Fyn decreased autophagy-mediated muscle mass by
directly inhibiting LKB1 and stimulating STAT3 activities, respectively. AMPK, a downstream
target of LKB1, was recently identified as a key molecule controlling autophagy. Here we
identified that Fyn phosphorylates the α subunit of AMPK on Y436 and inhibits AMPK
enzymatic activity without altering the assembly state of the AMPK heterotrimeric complex …
Abstract
We previously demonstrated that proto-oncogene Fyn decreased energy expenditure and increased metabolic phenotypes. Also Fyn decreased autophagy-mediated muscle mass by directly inhibiting LKB1 and stimulating STAT3 activities, respectively. AMPK, a downstream target of LKB1, was recently identified as a key molecule controlling autophagy. Here we identified that Fyn phosphorylates the α subunit of AMPK on Y436 and inhibits AMPK enzymatic activity without altering the assembly state of the AMPK heterotrimeric complex. As pro-inflammatory mediators are reported modulators of the autophagy processes, treatment with the pro-inflammatory cytokine TNFα resulted in 1) increased Fyn activity 2) stimulated Fyn-dependent AMPKα tyrosine phosphorylation and 3) decreased AICAR-dependent AMPK activation. Importantly, TNFα induced inhibition of autophagy was not observed when AMPKα was mutated on Y436. 4) These data demonstrate that Fyn plays an important role in relaying the effects of TNFα on autophagy and apoptosis via phosphorylation and inhibition of AMPK.
ncbi.nlm.nih.gov